Orphanet Journal of Rare Diseases

Article	Citations
Identification of a novel ST3GAL5 variant in a Chinese boy with GM3 synthase deficiency and literature review of variants in the ST3GAL5 gene	140
Clinical and biochemical characteristics of patients with ornithine transcarbamylase deficiency and in silico analysis of OTC gene	88
Derivation and validation of diagnostic models for myocardial fibrosis in duchenne muscular dystrophy: assessed by multi-parameter cardiovascular magnetic resonance	87
Istore: a project on innovative statistical methodologies to improve rare diseases clinical trials in limited populations	84
Unlocking access: a comprehensive analysis of medicines accessibility for rare diseases in Thailand	72
Disease risk estimates in V30M variant transthyretin amyloidosis (A-ATTRv) from Mallorca	68
Impact of brief telehealth interventions on parental stress and challenging behaviors of children with fragile X syndrome	68
Genetic evaluation of five patients with ROHHAD-NET using whole genome sequencing and optical genome mapping	64
Impact of progressive familial intrahepatic cholestasis on caregivers: caregiver-reported outcomes from the multinational PICTURE study	63
Efficacy and safety of compassionate use for rare diseases: a scoping review from 1991 to 2022	62
Composite endpoints, including patient reported outcomes, in rare diseases	62
French national diagnosis and care protocol (Protocole National De Diagnostic et de Soins; PNDS): Gaucher disease	61
Neurodegeneration or dysfunction in Phelan-McDermid syndrome? A multimodal approach with CSF and computational MRI	61
Whole-body MRI evaluation in neurofibromatosis type 1 patients younger than 3 years old and the genetic contribution to disease progression	58
The association of feeding difficulties and generic health-related quality of life among children born with esophageal atresia	57
Identification of ER/SR resident proteins as biomarkers for ER/SR calcium depletion in skeletal muscle cells	55
A global neuronopathic gaucher disease registry (GARDIAN): a patient-led initiative	52
7p22.3 microdeletion: a case study of a patient with congenital heart defect, neurodevelopmental delay and epilepsy	50
Intrauterine phenotype features of fetuses with 7q11.23 microduplication syndrome	49
First 100 patients receiving long-acting growth hormone therapy: real-world evaluation from INSIGHTS-GHT registry	49
Performance of the Egoo test for phenylalanine measurement in females with phenylketonuria	48
The burden of illness in Prader-Willi syndrome: a systematic literature review	48
Delineating family needs in the transition from hospital to home for children with medical complexity: part 2, a phenomenological study	47
Revealing shared molecular and mechanistic signatures between intracranial aneurysms and abdominal aortic aneurysms: a comprehensive genomic analysis	45
Rare disease clinical trials in the European Union: navigating regulatory and clinical challenges	45

Exploring molecular spectrum in thai patients with maple syrup urine disease: unveiling a common variant	44
How social pharmaceutical innovations are addressing problems of availability, accessibility and affordability of drugs for rare diseases	44
Parental Intervention Program for Preschool children with Rare Diseases – a mixed methods evaluation of parents’ experiences and utility	44
Efficacy of different treatment strategies in patients with mucopolysaccharidosis: a systematic review and network meta-analysis of randomized controlled trials	43
Multidisciplinary team meetings in treatment of spinal muscular atrophy adult patients: a real-life observatory for innovative treatments	43
Clinical and genetic characterization of congenital disorders of glycosylation in 20 Chinese patients	42
Increasing African genomic data generation and sharing to resolve rare and undiagnosed diseases in Africa: a call-to-action by the H3Africa rare diseases working group	42
Challenges and improvement needs in the care of patients with central diabetes insipidus	42
Clinical and genetic spectrum of 14 cases of NLRP3-associated autoinflammatory disease (NLRP3-AID) in China and a review of the literature	41
Pearson syndrome: a multisystem mitochondrial disease with bone marrow failure	40
Primary immune regulatory disorders: Undiagnosed needles in the haystack?	39
Patient experiences of interprofessional collaboration and intersectoral communication in rare disease healthcare in Germany – a mixed-methods study	39
In vivo applications and toxicities of AAV-based gene therapies in rare diseases	38
Diagnostic delay in rare diseases: data from the Spanish rare diseases patient registry	38
Identification of a novel de novo mutation of SETBP1 and new findings of SETBP1 in tumorgenesis	37
Clinical and genetic characterization of 47 Chinese pediatric patients with Pitt–Hopkins syndrome: a retrospective study	37
Epidemiology of Wilson disease in Germany – real-world insights from a claims data study	37
A father’s crusade in rare disease drug development: a case study of Elpida therapeutics and Melpida	35
Initial Psychometric Evaluation of the Barth Syndrome Symptom Assessment (BTHS-SA) for Adolescents and Adults in a Phase 2 Clinical Study	35
Correction to: Short-term safety results from compassionate use of risdiplam in patients with spinal muscular atrophy in Germany	34
Hereditary angioedema in Spain: medical care and patient journey	34
Parental experiences and needs of caring for a child with 22q11.2 deletion syndrome	34
The Tuscany Regional Network for rare diseases: from European Reference Networks’ experience to registry based organisation and management model for rare diseases	33
Objective measurement of oral function in adults with spinal muscular atrophy	33
Understanding caregiver descriptions of initial signs and symptoms to improve diagnosis of metachromatic leukodystrophy	32
A review and recommendations for oral chaperone therapy in adult patients with Fabry disease	32
Inventory of current practices regarding hematopoietic stem cell transplantation in metachromatic leukodystrophy in Europe and neighboring countries	32
A newborn Screening Programme for Inborn errors of metabolism in Galicia: 22 years of evaluation and follow-up	31
Therapeutic potential of living donor liver transplantation from heterozygous carrier donors in children with propionic acidemia	31
Late-onset fabry disease presenting with unexplained renal failure, left ventricular hypertrophy, and recurrent syncope: a case report	31
Dilated cardiomyopathy as the initial presentation of Becker muscular dystrophy: a systematic review of published cases	31
Recurrent angioedema manifestation and treatment response in two patients from different families caring the myoferlin gene mutation: case series	30
Symptoms and impacts of aromatic l-amino acid decarboxylase (AADC) deficiency among individuals with different levels of motor function	30
Maternal, fetal and neonatal outcomes among pregnant women with arthrogryposis multiplex congenita: a scoping review	30
Ending diagnostic odyssey by reanalysis of whole exome sequencing data: reclassification of suspected Fanconi anemia cases to dyskeratosis congenita and Diamond-Blackfan anemia	30
Single-cell sequencing analysis of peripheral blood in patients with moyamoya disease	30
Fragile X Syndrome and FMR1 premutation: results from a survey on associated conditions and treatment priorities in Italy	30
Genetic analysis of 37 cases with primary periodic paralysis in Chinese patients	30
A novel homozygous intronic variant in CDT1 that alters splicing causes Meier–Gorlin syndrome, and a review of published mutations and growth hormone treatments	29
Prevalence and gender - specific analysis of a systemic sclerosis cohort in Latvia	29
Acid sphingomyelinase deficiency in France: a retrospective survival study	29
Pediatric pulmonary multisystem langerhans cell histiocytosis: does lung lesion severity affect the outcome?	29
Hospital administrators as forgotten partners in rare disease care: a call to action by the international hospital federation’s global rare pediatric disease network	29
Exploring pathway interactions to detect molecular mechanisms of disease: 22q11.2 deletion syndrome	29
Diagnostic and therapeutic practices in adult chronic nonbacterial osteomyelitis (CNO)	28
An expanded clinical spectrum of hypoinsulinaemic hypoketotic hypoglycaemia	28
Identifying project topics and requirements in a citizen science project in rare diseases: a participative study	28
Bone disease and oromaxillofacial disorders: a cross- sectional study in a Tanzanian pediatric population	28
Designing rare disease care pathways in the Republic of Ireland: a co-operative model	28
Lung function decline preceding chronic respiratory failure in spinal muscular atrophy: a national prospective cohort study	28

Vitamin B12 in Leber hereditary optic neuropathy mutation carriers: a prospective cohort study	28
Areas of improvement in the medical care of SMA: evidence from a nationwide patient registry in Germany	27
Arginase 1 Deficiency: using genetic databases as a tool to establish global prevalence	27
The health-related quality of life, mental health and mental illnesses of patients with inclusion body myositis (IBM): results of a mixed methods systematic review	27
Ultrasound-guided interlaminar approach for nusinersen administration in patients with spinal muscular atrophy with spinal fusion or severe scoliosis	26
Management of pain in Fabry disease in the UK clinical setting: consensus findings from an expert Delphi panel	25
Clinical, biochemical and molecular analysis in a cohort of individuals with gyrate atrophy	25
Physician- and patient-reported perspectives on myasthenia gravis in Europe: a real-world survey	25
Prevalence and clinical characteristics of incontinentia pigmenti: a nationwide population-based study	25
Overweight and obesity in adult patients with phenylketonuria: a systematic review	25
Novel biallelic variants in IREB2 cause an early-onset neurodegenerative disorder in a Chinese pedigree	24
Living with a rare disease - experiences and needs in pediatric patients and their parents	24
Updates on the role of epigenetics in familial mediterranean fever (FMF)	23
Development of a patient journey map for people living with cervical dystonia	23
The Prader-Willi syndrome Profile: validation of a new measure of behavioral and emotional problems in Prader-Willi syndrome	23
Distribution of perivascular spaces distribution and relate to the clinical features of SCA3	23
Turner syndrome: French National Diagnosis and Care Protocol (NDCP; National Diagnosis and Care Protocol)	23
Sanfilippo syndrome: consensus guidelines for clinical care	23
Psychosocial implications of rare genetic skin diseases affecting appearance on daily life experiences, emotional state, self-perception and quality of life in adults: a systematic review	22
Late-onset symptomatic hyperprolactinemia in 6-pyruvoyl-tetrahydropterin synthase deficiency	22
Clinical classification, visual outcomes, and optical coherence tomographic features of 48 patients with posterior sympathetic ophthalmia	22
Symptoms and impacts of familial chylomicronemia syndrome: a qualitative study of the patient experience	22
Development of the Clinical Gestalt Assessment: a visual clinical global impression scale for Proteus syndrome	22
DNAH10 mutation cause primary ciliary dyskinesia with defects of IDAf complex assembly and lung fibrosis manifestation	22
Ring 18 chromosome associated with cleft palate: case report and comprehensive literature review of clinical symptoms	22
Retrospective longitudinal study on the long-term impact of COVID-19 infection on polysomnographic evaluation in patients with Prader-Willi syndrome	22
Lung function in adult patients with osteogenesis imperfecta: a cohort study	21
Clinical severity grading of NF2-related schwannomatosis	21
How does overweight affect bone mineral density and oral health in adult hypophosphatasia?– A single center experience	21
Quality of life in patients with acromegaly: a scoping review	21
Patient experience with pulmonary hypertension in Spain	21
Increased malignancy risk in patients with lymphangioleiomyomatosis: findings from a Chinese cohort	21
A novel TRPV4 variant in spondylometaphyseal dysplasia, kozlowski type reveals a previously unreported loss-of-function mechanism	21
Prioritisation of head, neck, and respiratory outcomes in mucopolysaccharidosis type II: lessons from a rare disease consensus exercise and comparison of parental and clinical priorities	21
Improving prognostic evaluations in patients with stage IIIb light chain cardiac amyloidosis: role of haemodynamic parameters	21
Optimal practices for the management of hereditary transthyretin amyloidosis: real-world experience from Japan, Brazil, and Portugal	20
Key patient-reported outcomes in children and adolescents with intoxication-type inborn errors of metabolism: an international Delphi-based consensus	20
Rates of mental health concerns among individuals assessed at the GoodHope Ehlers-Danlos Syndrome Clinic	20
Aspiration, respiratory complications, and associated healthcare resource utilization among individuals with Rett syndrome	20
Identification of two novel SALL1 mutations in chinese families with townes-brocks syndrome and literature review	20
Preferences for coordinated care for rare diseases: discrete choice experiment	20
Assessing the socio-economic burden of inherited and inflammatory neuromuscular diseases (BIND study): a study protocol	20
Unmet needs of adults living with mucopolysaccharidosis II: data from the Hunter Outcome Survey	20
Cardiac device implantation and device usage in Fabry and hypertrophic cardiomyopathy	20
Characterization of pathogenic genetic variants in Russian patients with primary ciliary dyskinesia using gene panel sequencing and transcript analysis	20
Using chanarin-dorfman syndrome patient fibroblasts to explore disease mechanisms and new treatment avenues	20
Towards FAIRification of sensitive and fragmented rare disease patient data: challenges and solutions in European reference network registries	20
Spectrum of IDH-mutant tumors in Ollier-Maffucci disease: the triple interaction theory	19
Analysis of genomic ancestry and characterization of a new variant in MPS type VII	19
Management of hereditary angioedema with normal C1Inh: a series of 163 French patients	19
Treatment regimens, patient reported outcomes and health-related quality of life in children with moderate and severe hemophilia A in China: using real-world data	19
Newborn screening facilitates early theranostics and improved spinal muscular atrophy outcome: five-year real-world evidence from Taiwan	19
What is the awareness of rare diseases among medical students? A survey in Bulgaria	19
Health-related quality of life and family functioning in parents of children with Barth syndrome: an application of the Double ABCX model	19
Acute hepatic porphyria in Denmark; a retrospective study	19
Clinical characteristics of multicentric reticulohistiocytosis and distinguished features from rheumatoid arthritis: a single-center experience in China	19
Limited efficacy of tocilizumab in adult patients with secondary hemophagocytic lymphohistiocytosis: a retrospective cohort study	19
Challenges and opportunities with providing genetic testing and counseling for mucopolysaccharidosis type II in Kenya	19
Myocardial native T1 mapping and extracellular volume quantification in asymptomatic female carriers of Duchenne muscular dystrophy gene mutations	19
Ketogenic diet as a glycine lowering therapy in nonketotic hyperglycinemia and impact on brain glycine levels	18
Optimising care and follow-up of adults with achondroplasia	18
Epidemiological characterization of rare diseases in Brazil: A retrospective study of the Brazilian Rare Diseases Network	18
Practices and challenges for hemophilia management under resource constraints in Thailand	18
Colorectal cancer in Lynch syndrome families: consequences of gene germline mutations and the gut microbiota	18
Effects of asfotase alfa on fracture healing of adult patient with hypophosphatasia and literature review	18
Caregivers’ experiences and challenges of the diagnostic odyssey in Dravet syndrome	17
The Global Hypophosphatasia Registry: lessons learned from a decade of real-world data	17
Clinical measurement of cellular DNA damage hypersensitivity in patients with DNA repair defects	17
A phase 4, open-label, multicenter study of the safety and efficacy of agalsidase beta in Chinese patients with Fabry disease	17
Scoliosis in osteogenesis imperfecta: identifying the genetic and non-genetic factors affecting severity and progression from longitudinal data of 290 patients	17
Off-label use of medicines in South Africa: a review	17
An underestimated factor for therapeutic decision-making in rare diseases: parents' (un)knowledge—the example of Duchenne muscular dystrophy caregivers and non-invasive ventilation	17
Discovery of newborn Wilson disease biomarkers via integrated next-generation sequencing and untargeted metabolomics	17
Evaluation of NACA and diNACA in human cystinosis fibroblast cell cultures as potential treatments for cystinosis	17
HINT1 neuropathy in Lithuania: clinical, genetic, and functional profiling	17
Unique clinical and electrophysiological features in the peripheral nerve system in patients with sialidosis – a case series study	17
SplenoMegaly study (SMS): exploring the etiologies for “unexplained” splenomegalies in the real world	17
Status and frontiers of Fabre disease	17
The value of knowing: preferences for genetic testing to diagnose rare muscle diseases	17
Minimal encephalopathy in hereditary hemorrhagic telangiectasia patients with portosystemic vascular malformations	17

Evaluating the relationship between caregiver depression, social support, and children’s internalizing and externalizing symptoms in families affected by 22q11.2 deletion syndrome	17
Erythropoietic protoporphyria linked to intricate double heterozygous mutations in theFECH gene: a case report and literature review	17
Clinical and molecular genetic characteristics of pediatric PFIC3 patients: three novel variants and prognosis for parental liver transplantation	17
Nutritional status and metabolic alterations in patients with ataxia-telangiectasia	17
Healthcare resource utilization, total costs, and comorbidities among patients with myotonic dystrophy using U.S. insurance claims data from 2012 to 2019	16
Validation of the self-report quantified Tuberous Sclerosis Complex-Associated Neuropsychiatric Disorders Checklist (TAND-SQ)	16
A Natural History Study of Timothy Syndrome	16
Imprinting disorders as a window to understand pediatric feeding disorders	16
Genetic analysis using next-generation sequencing and multiplex ligation probe amplification in Chinese aniridia patients	16
Differences in swallowing efficacy of disease modifying treatment between infants receiving pre-symptomatic and symptomatic administration	16
A lack of race and ethnicity data in the treatment of hereditary hemorrhagic telangiectasia: a systematic review of intravenous bevacizumab efficacy	16
A unicentric cross-sectional observational study on chronic intestinal inflammation in total colonic aganglionosis: beware of an underestimated condition	16
Chromosomal abnormalities related to fever of unknown origin in a Chinese pediatric cohort and literature review	16
Psychometric evaluation of the Indolent Systemic Mastocytosis Symptom Assessment Form (ISM-SAF©) and determination of a threshold score for moderate symptoms	16
Coronary periarteritis and pericarditis are rare but distinct manifestations of heart involvement in IgG4-related disease: a retrospective cohort study	16
The influence of professionals’ personal views and values in the development of guidelines for rare diseases: an example from phenylketonuria	16
Delineation of the phenotypes and genotypes of facial infiltrating lipomatosis associated with PIK3CA mutations	16
COVID-19 in Fabry disease: a reference center prospective study	16
Father-to-daughter transmission in late-onset OTC deficiency: an underestimated mechanism of inheritance of an X-linked disease	16
Self-reported functioning among patients with ultra-rare nemaline myopathy or a related disorder in Finland: a pilot study	16
Association of MTHFR rs1801133 and homocysteine with Legg–Calvé–Perthes disease in Mexican patients	16
The challenges of classical galactosemia: HRQoL in pediatric and adult patients	16
Clinical outcomes of exclusive enzyme therapy (laronidase) in a cohort of patients with mucopolysaccharidosis type I	16
A diagnostic support system based on pain drawings: binary and k-disease classification of EDS, GBS, FSHD, PROMM, and a control group with Pain2D	16
Patient interest in the development of a center for Ehlers-Danlos syndrome/hypermobility spectrum disorder in the Chicagoland region	16
Assessment, pharmacological therapy and rehabilitation management of musculoskeletal pain in children with mucopolysaccharidoses: a scoping review	16
Healthcare resource utilization of patients with mitochondrial disease in an outpatient hospital setting	15
Characteristics and therapeutic outcomes of subcutaneous panniculitis-like T-cell lymphoma with and without germline HAVCR2 mutations in Thai children and adolescents	15
The economic impact of caregiving for individuals with Angelman syndrome in the United States: results from a caregiver survey	15
Correction to: The evolution of the mitochondrial disease diagnostic odyssey	15
Global variations in diagnostic methods and epidemiological estimates in Pompe disease: findings from a scoping review	15
Screening for lysosomal diseases in a selected pediatric population: the case of Gaucher disease and acid sphingomyelinase deficiency	15
A case report on Madelung’s disease and comprehensive review of the literature	15
Consensus statement on enzyme replacement therapy for mucopolysaccharidosis IVA in Central and South-Eastern European countries	15
Health-related quality of life of X-linked hypophosphatemia in Spain	15
Analysis of Incentive Policies and Initiatives on Orphan Drug Development in China: Challenges, Reforms and Implications	15
Unlocking sociocultural and community factors for the global adoption of genomic medicine	15
Increasing incidence rate of breast cancer in cystic fibrosis - relationship between pathogenesis, oncogenesis and prediction of the treatment effect in the context of worse clinical outcome and progn	15
Clinicopathological features, treatment outcomes, and prognostic factors of angiosarcoma: a 21-year experience at one center	15
Leaving no patient behind! Expert recommendation in the use of innovative technologies for diagnosing rare diseases	15
Operational description of rare diseases: a reference to improve the recognition and visibility of rare diseases	15
Targeted literature review exploring the predictive value of estimated glomerular filtration rate and left ventricular mass index as indicators of clinical events in Fabry disease	15
Evaluating the national system for rare diseases in China from the point of drug access: progress and challenges	15
Correction: Multivariate analysis and model building for classifying patients in the peroxisomal disorders X-linked adrenoleukodystrophy and Zellweger syndrome in Chinese pediatric patients	15
Risk factors, stroke rates and aspirin prescribing trends in the Canadian Fabry disease initiative cohort	15
European Reference Network (ERN) ReCONNET methodology for the cross-cultural adaptation of instruments for research and care in the context of rare connective tissue diseases (CROSSADAPT)	15
An estimation of global genetic prevalence of PLA2G6-associated neurodegeneration	15
A scoping review of health literacy in rare disorders: key issues and research directions	14
Phenotype expansion of variants affecting p38 MAPK signaling in hypospadias patients	14
Prevalence of hearing loss in pseudohypoparathyroidism	14
Altered oral microbiome, but normal human papilloma virus prevalence in cartilage-hair hypoplasia patients	14
Review of a specialist Rett syndrome clinic from 2003 to the COVID pandemic: clinic experience and carer perspectives	14
Gastrointestinal Kohlmeier–Degos disease: a narrative review	14
Arthrogryposis Multiplex Congenita (AMC) and counselling before and during pregnancy: a questionnaire study	14
A cohort of GFPT1 related congenital myasthenic syndrome in China: high frequency of c.331 c > t variant	14
XLH Matters 2024: expert insights and practical tools for enhancing care of people living with X-linked hypophosphataemia	14
Historical and projected public spending on drugs for rare diseases in Canada between 2010 and 2025	14
Helping the medicine go down: the role of the healthcare professional in a young person’s experience of achalasia, a rare oesophageal motility disorder	14
French national diagnosis and care protocol (PNDS, protocole national de diagnostic et de soins): cystic lymphatic malformations	14
Mortality in patients with alpha-mannosidosis: a review of patients’ data and the literature	14
Clinical and genetic spectrum of GSD type 6 in Korea	14
Single large-scale mitochondrial DNA deletion syndromes: scientific and family conference optimizes the collection of rare disease research outcomes	14
Development and evaluation of a patient-reported outcome measure specific for Gaucher disease with or without neurological symptoms in Japan	14
Drug-associated porphyria: a pharmacovigilance study	14
Experienced fatigue in people with rare disorders: a scoping review on characteristics of existing research	14
Favourable outcome of acute hepatitis E infection in patients with ANCA-associated vasculitis	14
Intracranial vasculopathy: an important organ damage in young adult patients with late-onset Pompe disease	14
Burden of illness in Rett syndrome: initial evaluation of a disorder-specific caregiver survey	14
A natural history study of pediatric patients with early onset of GM1 gangliosidosis, GM2 gangliosidoses, or gaucher disease type 2 (RETRIEVE)	14
Identification of novel MYO19 variants in neonatal hypertrophic cardiomyopathy: a familial analysis revealing oligogenic contributors to disease severity	14
Recommendations for management of infants and young children with achondroplasia: Does clinical practice align?	14
Exercise capacity in RYR1-related myopathies	14
A single-centre retrospective study on the clinical characteristics of patients with hereditary angioedema and the therapeutic effect of lanadelumab	13
Burden of rare genetic disorders in India: twenty-two years’ experience of a tertiary centre	13
Late-onset Pompe’s disease in pediatrics: results from an Italian national survey on 38 patients and proposal of a targeted diagnostic algorithm	13
Rare variants in alpha 1 antitrypsin deficiency: a systematic literature review	13
Transformative effect of a Humanitarian Program for individuals affected by rare diseases: building support systems and creating local expertise	13
A real-world analysis of the impact of X-linked myotubular myopathy on caregivers in the United States	13
Identifying responders to elamipretide in Barth syndrome: Hierarchical clustering for time series data	13
Diagnosis and treatment of the Ehlers-Danlos syndromes in China: synopsis of the first guidelines	13
Shifting focus from ideality to reality: a qualitative study on how quality of life is defined by premanifest and manifest Huntington’s disease gene expansion carriers	13
Understanding the ecosystem of patients with lysosomal storage diseases in Spain: a qualitative research with patients and health care professionals	13
Genotype-phenotype associations in microtia: a systematic review	13
Childhood to adult transition in youth patients with lysosomal acid lipase deficiency: 43 recommendations from experts	13
Pharmacovigilance for rare diseases: a bibliometrics and knowledge-map analysis based on web of science	13
Identification of strengths and weaknesses of the healthcare system for persons living with rare diseases in Catalonia (Spain), and recommendations to improve its comprehensive attention: the “acERca	13
Long-term outcome and fertility results of intraplacental choriocarcinoma: a retrospective study of 14 patients and literature review	13
Health outcomes following COVID-19 infection and vaccination in hereditary hemorrhagic telangiectasia	13
The Italian registry for patients with Prader–Willi syndrome	13
Primary URECs: a source to better understand the pathology of renal tubular epithelia in pediatric hereditary cystic kidney diseases	13
Decentralized clinical trials and rare diseases: a Drug Information Association Innovative Design Scientific Working Group (DIA-IDSWG) perspective	13
Usefulness of levels of 2-methylbutyrylglycine and 2-ethylhydracrylic acid in urine for diagnosing 2-methylbutyrylglycinuria	13
Conjoint analysis of methylation, transcriptomic, and proteomic profiles in pemphigus vulgaris	13
A standard set of outcome measures for the comprehensive assessment of oral health and occlusion in individuals with osteogenesis imperfecta	13
How do patients and other members of the public engage with the orphan drug development? A narrative qualitative synthesis	13